Energy Fuels Inc

Energy Fuels Inc (NYSE: UUUU) is a globally focused critical minerals company with a diversified asset base across uranium, rare earth elements (REEs), heavy mineral sands, vanadium, and medical isotopes. The company operates a range of conventional and in-situ recovery uranium assets in the western United States. It also holds three key heavy mineral sands projects, including the wholly owned Toliara (Vara Mada) Project in Madagascar, the Bahia Project in Brazil, and a stake in the Donald Project in Australia.

As per our previous Kalkine’s Global Critical Minerals Report published on ‘UUUU’ on March 27, 2026, we provided a ‘Buy’ stance on the stock at USD 17.66 based on “price action, recent key business and financial updates, momentum in the stock over the last month, and technical indicators analysis” and has generated a return of 38.45% with attainment of resistance 1 and resistance 2.

Noted below are the details of support and resistance levels provided in our previous report:

Rationales for “Sell” on UUUU:

Persistent Net Losses and Limited Near-Term Profitability: Despite improved year-over-year performance, Energy Fuels Inc. (UUUU) continued to report a net loss of approximately USD 10.8 million in Q1 2026, highlighting ongoing challenges in translating operational progress into sustainable profitability. While uranium revenues increased to roughly USD 35.7 million, profitability remains highly dependent on favorable commodity pricing, successful scaling of rare earth operations, and disciplined cost execution. The company’s diversified expansion strategy across uranium, rare earths, mineral sands, and medical isotopes may continue to pressure margins due to elevated development and administrative expenditures.

Large Capital Requirements and Project Execution Risk: UUUU’s long-term growth strategy involves multiple capital-intensive projects, including the planned Phase 2 rare earth expansion at the White Mesa Mill with estimated initial capital costs of approximately USD 410 million, alongside development initiatives in Madagascar, Australia, Brazil, and the U.S. Several projects remain subject to final investment decisions, permitting approvals, financing availability, and construction execution. Delays, cost overruns, or financing constraints could materially impact projected returns and weaken the company’s ability to commercialize its vertically integrated critical minerals platform efficiently.

Commodity Price Volatility and Revenue Sensitivity: The company remains highly exposed to uranium and rare earth element price fluctuations, which can materially affect revenues, margins, inventory valuations, and project economics. Although uranium prices remain relatively supportive, realized pricing across long-term contracts remained below spot market levels during Q1 2026, limiting upside capture. In addition, rare earth markets remain volatile and heavily influenced by Chinese supply dynamics, geopolitical developments, and demand uncertainty tied to electric vehicles, renewable energy, and defense sectors, creating earnings unpredictability for future REE operations.

Regulatory, Jurisdictional, and Permitting Risks: UUUU’s global development portfolio exposes the company to substantial regulatory and geopolitical risks across multiple jurisdictions, including Madagascar, Brazil, Australia, and the United States. The Vara Mada project in Madagascar remains dependent on fiscal negotiations, parliamentary approvals, updated permits, and broader political stability before development can proceed. Similarly, several uranium and rare earth projects require ongoing environmental clearances, mining permits, and operational licenses, which may delay timelines, increase compliance costs, or restrict future expansion opportunities.

Operational Complexity and Diversification Challenges: The company is simultaneously advancing uranium production, REE separation capacity, heavy mineral sands projects, and medical isotope initiatives, creating significant operational complexity and execution demands. Managing multiple technically specialized businesses across mining, chemical processing, refining, and advanced materials increases operational risk and may dilute management focus. In addition, several initiatives — including heavy REE commercialization and medical isotope production — remain at early-stage or pilot-scale development phases with uncertain long-term economic viability and commercialization timelines.

Daily Chart

Considering the substantial capital requirements associated with advancing multiple uranium, rare earth, mineral sands, and downstream processing projects despite favorable long-term critical minerals demand trends, continued earnings pressure from ongoing development expenditures and project execution risks, significant dependence on commodity price strength and successful commercialization of planned REE expansion initiatives, regulatory and permitting uncertainties across global assets, and elevated operational complexity tied to simultaneously scaling multiple strategic growth platforms, a ‘Sell’ rating is assigned to the ‘UUUU’ at the current market price of USD 24.45, as of May 07, 2026, at 07:20 am PDT.

Note: This report may be updated with details around fundamental and technical analysis, price chart in due course, as appropriate.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is May 07, 2026. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.